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http://www.molecularbrain.com/content/7/1/39RESEARCH Open AccessExtrasynaptic GABAA receptors in mediodorsal
thalamic nucleus modulate fear extinction learning
Afshin Paydar1,2, Boyoung Lee1, Gireesh Gangadharan1, Sukchan Lee1, Eun Mi Hwang2,3 and Hee-Sup Shin1,2*Abstract
Background: The gamma-amino-butyric acid (GABA) system is a critical mediator of fear extinction process. GABA
can induce “phasic” or “tonic” inhibition in neurons through synaptic or extrasynaptic GABAA receptors, respectively.
However, role of the thalamic “tonic GABA inhibition” in cognition has not been explored. We addressed this issue
in extinction of conditioned fear in mice.
Results: Here, we show that GABAA receptors in the mediodorsal thalamic nucleus (MD) modulate fear extinction.
Microinjection of gabazine, a GABAA receptor antagonist, into the MD decreased freezing behavior in response to the
conditioned stimulus and thus facilitated fear extinction. Interestingly, microinjection of THIP (4,5,6,7-tetrahydroisoxazolo
[5,4-c]pyridin-3-ol), a preferential agonist for the δ-subunit of extrasynaptic GABAA receptors, into the MD attenuated fear
extinction. In the opposite direction, an MD-specific knock-out of the extrasynaptic GABAA receptors facilitated fear
extinction.
Conclusions: Our results suggest that “tonic GABA inhibition” mediated by extrasynaptic GABAA receptors in
MD neurons, suppresses fear extinction learning. These results raise a possibility that pharmacological control of
tonic mode of GABAA receptor activation may be a target for treatment of anxiety disorders like post-traumatic
stress disorder.
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Anxiety disordersBackground
A failure in inhibition of maladaptive associative re-
sponses to environmental stimuli is a hallmark of anxiety
disorders such as phobias and post-traumatic stress dis-
order (PTSD). Dysfunctional neural responses underlie
such disorders [1]. Fear extinction in animals is used for
understanding these disorders and developing methods
for their treatment. In fear extinction repetitive expo-
sures of a fear-conditioned animal to the conditional
stimulus (CS) in the absence of the unconditional stimu-
lus (US) will result in a decrease of the conditional
response (CR), freezing behavior [1-3]. An impairment
of fear extinction has been reported in several mouse* Correspondence: shin@ibs.re.kr
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unless otherwise stated.mutants [4,5], providing an opportunity where the
neural mechanism underlying PTSD may be delineated.
GABA has an essential role in fear extinction through
modulating cellular activities in the amygdala, medial
prefrontal cortex (mPFC), and hippocampus, key struc-
tures involved in fear extinction [3,6-12]. However,
there has been controversies regarding the exact role of
GABAergic cells or receptors in fear extinction [2,6].
For a better understanding of detailed mechanisms of
fear extinction, the role of the GABAergic system, espe-
cially in its control of neuronal firing modes, needs to
be elucidated.
The inhibition in thalamocortical (TC) neurons is medi-
ated predominantly through ionotropic GABAA receptors
(GABAARs) [13,14]. TC neurons exhibit two different
modes of GABAAR-mediated inhibition; a transient “phasic
inhibition” through α1β2γ2 synaptic receptors, and a con-
tinuous “tonic inhibition” mediated by α4β2δ extrasynaptic
GABAAR (eGABAARs) [14-16]. Modulation of GABAARs
activities, especially eGABAARs, contributes to the shiftLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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motes the transition between different behavioral states in
absence seizure animal models [17-20]. However, the
physiological role of thalamic tonic GABA inhibition in
cognitive behaviors is not known.
The mediodorsal nucleus (MD) of thalamus, a part of
the TC system in the thalamus, receives GABAergic
afferents from multiple brain regions including ventral
pallidum, substantia innominata, globus pallidus, nucleus
reticularis thalami and substantia nigra pars reticulata
[21,22]. The MD has interconnections with the key regions
of the fear extinction circuits, mPFC and amygdala [21-23].
Unilateral bicuculline infusion into the MD induces ipsi-
and contralateral c-fos expression in the mPFC [24]. MD
neurons exhibit dual modes of firing, burst or tonic,
and the firing mode of MD neurons can modulate
fear extinction bidirectionally; tonic firing facilitates,
whereas burst firing attenuates extinction [5]. Tonic
firing results from membrane depolarization, while
burst firing is induced by membrane hyperpolarization
following inhibitory inputs. However, the details of the
mechanisms for inducing hyperpolarization of MD
neurons in fear extinction suppression have not been
defined.
In this study, we investigated the role of eGABAARs in
the MD in fear extinction using pharmacological and
genetic tools in mice. We found that the extrasynaptic
GABAARs in the MD suppress fear extinction learning.
Results
Injection of gabazine into the MD facilitates fear
extinction
To test the effect of GABAARs activities in the MD
on fear extinction learning, we injected gabazine, a
GABAAR inhibitor, into the MD of wild-type mice
(Figure 1A-B). In day 1 (conditioning), we exposed the
cannula-implanted mice to three trials of tone (CS),
each co-terminated with an electric foot shock (US). In
day 2 (extinction learning), 30 min after injection of
gabazine or vehicle through the cannula, the fear-
conditioned mice were exposed to 20 repeated CS-only
trials. In the extinction learning gabazine-injected mice
showed a faster decrease in freezing levels compared to
the mice in the vehicle-injected group (two-way re-
peated measures ANOVA, group effect, F1,21 = 71.745,
P < 0.001; group × trial interaction, F21,399 = 5.414,
P < 0.001; Figure 1C). In comparison with the mice in
the vehicle-injected group, the gabazine-injected mice
showed lower initial levels of freezing (t test; P =
0.0001; Figure 1C). Therefore, to compare the rates of
within-session extinction between the two groups, the
freezing levels for trials in each group were normalized
to the value for the first trial of each group (Figure 1D)
following the convention [25,26]. There was a differencebetween groups (two-way repeated measures ANOVA,
group effect, F1,21 = 55.024, P < 0.001; group × trial inter-
action, F21,399 = 5.318, P < 0.001), indicating that gabazine
injection into the MD has changed the extinction rate. In
the third day (extinction recall), mice were re-exposed to
the CS without the US. The gabazine-treated group showed
significantly lower freezing levels than the vehicle-injected
group (t test, P = 0.0001; Figure 1C), indicating that gaba-
zine facilitated extinction learning in the mice.
To rule out the possible confounding effect of
GABAARs activity in the MD on the locomotion and anx-
iety level of the mice, we injected gabazine or vehicle into
the MD of the mice 30 min before performing an open
field test. The two groups did not differ in total distance
moved during a 1 hr period in the open field arena (t test,
P = 0.365; Figure 1E), and showed no significant difference
in the percentage of time spent in the central area
compared to the whole arena in the first 5 min
(Mann–Whitney Rank Sum Test, P = 0.758; Figure 1F),
indicating that the lower freezing response of gabazine-
injected mice was not the result of an increased locomotor
activity in the extinction box or decreased anxiety.
Injection of THIP into the MD attenuates fear extinction
The α4β2δ eGABAARs are highly expressed in the thal-
amus including the MD [27,28]. To test whether eGA-
BAARs activity in the MD could affect fear extinction
learning, we injected THIP (4,5,6,7-tetrahydroisoxazolo
[5,4-c]pyridin-3-ol), a selective GABAAR agonist with a
preference for δ-subunit containing eGABAARs [29], into
the MD 30 min before fear extinction learning. During the
extinction learning, the THIP-injected mice showed
less decrease in freezing levels than the vehicle-
injected group (two-way repeated measures ANOVA,
group effect, F1,16 = 32.315, P < 0.001; group × trial
interaction, F16,304 = 0.665, P < 0.852; Figure 2A). Due
to higher freezing levels in the first trial in the THIP-
injected group compared with the vehicle-injected
group (t test; P = 0.00003; Figure 2A), we further exam-
ined the rates of within-session extinction between the
two groups by normalizing freezing levels to that of the
first trial for each group (Figure 2B) following the
convention [25,26]. There was significant difference be-
tween the two groups in the rates of within-session ex-
tinction (two-way repeated measures ANOVA, group
effect, F1,16 = 12.127, P = 0.003; group × trial inter-
action, F16,304 = 1.065, P < 0.387). This indicates that
THIP injection changed within-session extinction rate. In
the extinction recall, the THIP-treated group showed sig-
nificantly higher freezing levels than the vehicle-injected
group (t test, P = 0.002; Figure 2A), indicating that THIP at-
tenuated extinction learning in the mice.
To check the possible effect of eGABAARs activity in
the MD on the locomotion and anxiety level of the mice,
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Figure 1 Gabazine injection into the MD facilitates fear extinction. (A) experiment scheme. (B) Injection target. (C) Injection of gabazine
(30 μM) into the MD (empty circles, n = 12) 30 min before extinction decreased freezing levels in both extinction learning, and the recall test
in the next day compared with the mice that received vehicle injection into the MD (filled circles, n = 11), ↑, injection time point. (D) Normalized
within-session extinction to percentage of the initial freezing levels of each group shows group difference and group x trial interaction in extinction
rate. (E and F) No difference between these two groups in the locomotion, or anxiety. Data are means ± SEM.
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30 min before performing an open field test. The two
groups did not differ in locomotion during a 1 hr period
(t test; P = 0.200; Figure 2C), and showed no significant
difference in the percentage of the time spent in the cen-
tral area compared to the whole arena in the first 5 min
(t test; P = 0.702; Figure 2D), which means that the
higher freezing response of the THIP-injected mice was
not due to a change in the locomotor activity or anxiety.
Conditional Knock-out (KO) of GABRA4 in the MD facilitates
fear extinction
As thalamic expression of the α4-subunit is limited to
the extrasynaptic area [16,27], we tested the behavioral
effect of MD-specific KO of GABRA4 gene in the fear
extinction paradigm. AAV-mCherry (control virus) or
AAV-mCherry-Cre viral particles were injected into
the MD of GABRA4flx/flx mice 3 weeks before fear
conditioning (Figure 3A). Immunohistochemistry was
used to test Cre expression and functionality. Cre ex-
pression can be seen in the mCherry-expressing cells
in the MD region of the mice injected with AAV-
mCherry-Cre (Figure 4A-B). A lack of GABRA4 ex-
pression in the injected side of the MD in brainslices from the Cre virus-injected mice is evident
when compared with the contralateral non-injected
side or slices from the control virus-injected mice
(Figure 4C).
There was no difference between the two groups in
fear conditioning (two-way repeated measures ANOVA,
group effect, F1,15 = 4.109, P = 0.061; group × trial inter-
action, F15,60 = 0.365, P = 0.832; Figure 3B). There was
no significant difference in the initial freezing levels be-
tween the two groups (t test; P = 0.186; Figure 3B). How-
ever, the mice injected with AAV-mCherry-Cre showed
faster extinction learning compared to the control group
(two-way repeated measures ANOVA, group effect, F1,15
= 9.947, P = 0.007; group × trial interaction, F15,285 = 1.111,
P = 0.338; Figure 3B). In the extinction recall test, the group
injected with AAV-mCherry-Cre showed significantly lower
freezing levels than the control virus-injected group (t test;
P = 0.018; Figure 3B), indicating that GABRA4-deletion
facilitated extinction learning in the mice.
The two groups did not differ in locomotion (t test,
P = 0.679; Figure 3C) or the percentage of the time
spent in the central area compared to the whole arena
in the first 5 min (Mann–Whitney Rank Sum Test,
P = 0.880; Figure 3D), indicating that the lower freezing
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Figure 2 THIP injection into the MD attenuates fear extinction. (A) THIP injection (50 μM) into the MD (empty circles, n = 11) 30 min before
extinction increased freezing levels in both extinction learning, and a day after that in the recall test compared with the mice that received
vehicle injection into the MD (filled circles, n = 7), ↑, injection time point. (B) Normalizing within-session extinction to percentage of initial freezing
levels of each group shows a difference in extinction rate between the two groups. (C and D) There was no difference between the two groups
in the locomotion or anxiety level. Data are means ± SEM.
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result of increased locomotor activity or decreased
anxiety.
Discussion
In this study we found that activity of GABAARs, especially
α4- and δ-containing eGABAARs in the MD can suppressfear extinction. As we previously reported the firing mode
of MD neurons modulates fear extinction bidirectionally;
tonic firing facilitates, while burst firing attenuates extinc-
tion learning [5]. Individual action potentials of tonic firing
occurs during membrane depolarization, while burst firing
is induced by low-threshold calcium spikes mediated by
low-voltage activated T-type calcium channels that are
AB
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Figure 3 Virus-mediated conditional KO of GABRA4 in the MD facilitates extinction. (A) Experiment scheme. (B) The GABRA4flx/flx mice injected with
AAV-mCherry (filled circles, n= 6) or AAV-mCherry-Cre (empty circles, n= 11) into the MD showed no difference in fear conditioning. The Cre-virus injected
group showed significantly lower freezing levels in the extinction learning and the recall test in comparison to the control virus injected group. (C and D)
The two groups did not differ in the locomotion or anxiety. Data are means ± SEM.
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tory inputs [13,17]. Rich GABAergic inputs to the MD can
hyperpolarize neuronal membranes through the activation
of α1β2γ2 synaptic or α4β2δ extrasynaptic GABAARs,
resulting in a discrete “phasic inhibition” or a continuous
“tonic inhibition”, respectively. This can modulate MD neu-
rons firing pattern toward the bursting mode [14,17], and
as we found attenuated fear extinction.
The GABAergic system in the amygdala [7,8], hippocam-
pus [7,11] and mPFC [7,10] is involved in fear extinction,
although there are some controversies regarding the exact
roles of GABAergic cells or receptors in fear extinction
[2,6]. Our results which showed the suppressive role of
tonic inhibition in the MD in fear extinction may provide
better insight into the detailed mechanisms underlying the
GABAergic control of fear extinction.Moreover, current findings confirm our previous study
showing the role of the MD in fear extinction [5].
Consistently, elevated metabolism in the MD has been
observed in relation to fear extinction [30]. Furthermore,
it has been shown that prefrontal long-term potentiation
induced by high-frequency stimulation of the MD facili-
tates retention of extinction, while prefrontal long-term
depression induced by low-frequency stimulation of the
MD has the opposite effect [31].
In our pharmacologic interventions (microinjection of
gabazine or THIP into the MD) we found significant
differences in the initial freezing levels in extinction
between the drug-injected and vehicle-injected groups.
This could show a potential role of the MD in fear
memory retrieval and/or the fear response itself. There-
fore, to avoid this confounding effect and evaluate the
AAV-mCherry AAV-mCherry-CreA B
DAPI mCherry DAPI mCherry
MergedCre Cre Merged
C AAV-mCherry AAV-mCherry-Cre
Figure 4 Cre expression and GABRA4 KO in the transfected MD cells. (A and B) Opposite to the MD cells from the mice injected with AAV-mCherry,
immunofluorescence revealed Cre expression (green) in the mCherry-expressing cells in the MD region of the mice injected with AAV-mCherry-Cre. (C) A
decrease of GABRA4 expression can be seen in the injected side of the MD in the Cre virus-injected mice compared with the contralateral non-injected
side or the control virus-injected mice. Arrows indicate the injection sites. Scale bars: 500 μm (top), and 250 μm (bottom).
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within-session extinction between the two groups by
normalizing the freezing levels for trials in each group to
the value for the first trial of that group following the
convention [25,26]. There were significant differences
between the two groups in the rates of within-session
extinction (Figures 1D and 2B). These results indicate
that gabazine or THIP injection changed rate of within-
session extinction, confirming the role of the MD in fear
extinction. However, in the case of GABRA4 conditional
KO there was no significant difference in the initial
freezing levels between the two groups. The different ef-
fects on the first trials of extinction between pharmaco-
logic and genetic interventions could be due to the fact
that drug effects are acute, while the gene KO is long
lasting and can induce compensatory changes. Moreover,drugs usually have effects on other receptor subtypes
and are not completely specific, while GABRA4 KO is
specific to eGABAARs in the MD. Nevertheless, these
results show that there are indeed differences in extinc-
tion between the interventions and control groups. Fur-
thermore, we clearly showed differences between the
groups in extinction retrieval experiments, which test
the extinction memory. Taken together, these show that
the extrasynaptic GABAARs in the MD modulate fear
extinction.
We found that inhibition of the GABAARs in the MD
through microinjection of gabazine facilitated fear ex-
tinction (Figure 1C). According to Cope et al. (2005)
gabazine promotes tonic firing in the TC cells. There-
fore, increase of tonic firing by inhibition of GABAARs
in the MD, a subregion of TC nuclei, would facilitate
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lesions, Garcia et al. (2006) did not find any role of the
mPFC and MD in fear extinction [32]. Interestingly, the
same group has a contrary report, showing that MD-
mPFC transmission and plasticity has a role in fear
extinction [33]. Moreover, shortcoming of electrolytic le-
sion is that it destroys all cell types and passing fibers
permanently, thus producing a compound effect [34].
On the other hand, we showed that the activation
of eGABAARs in the MD using THIP attenuates fear ex-
tinction (Figure 2A). It is well known that TC neurons
show a persistent “tonic inhibition” through α4β2δ
eGABAARs [14,35]. As reported previously, THIP, a
δ-subunit preferring GABAAR agonist, enhances tonic
inhibitory currents in TC neurons and promotes burst
firing by hyperpolarizing TC neurons [17]. Therefore,
increase of burst firing through the activation of eGA-
BAARs would suppress acquisition of fear extinction;
thus increasing the tonic inhibition attenuates fear ex-
tinction. These results are consistent with our previous
work on the bidirectional modulation of fear extinction by
thalamic firing modes [5]. However, Padilla-Coreano et al.
(2012) reported no change in fear extinction memory with
the injection of muscimol, a GABAAR agonist, into the
midline thalamus, including the MD, paraventricular, and
centromedial nuclei, in rats [36]. It has been reported that
muscimol can show opposite effects at different concentra-
tions [37]. Therefore, this difference could also be due to
injection of a high concentration of this drug in the study
mentioned above.
Lack of tonic inhibition in the TC neurons in
GABAAR α4-subunit (GABRA4) KO mice and exclu-
sively extrasynaptic location of α4-subunits in this re-
gion [27] makes α4-subunit containing eGABAARs an
excellent tool for studying the effect of the removal of
tonic inhibition in the thalamus. We found that virus-
mediated conditional KO of GABRA4 in the MD facili-
tates extinction learning. Interestingly, this finding is
also in concordance with our previous report showing
the role of the MD in fear extinction [5].
Conclusions
Our results obtained by pharmacological and genetic
tools show the involvement of GABAergic system in the
MD in fear extinction, especially through the eGA-
BAARs. Our findings suggest that “tonic GABA inhib-
ition” mediated by α4β2δ eGABAARs in MD neurons,
suppresses fear extinction learning. This provides further
support to the idea of the thalamic modulation of fear
extinction [5] and identifies the eGABAARs as a key me-
diator in this process.
Anxiety disorders, such as PTSD, panic disorder and
phobias have a substantial psychiatric and social bur-
den for both the patients and society, which calls forextensive clinical interventions for treatments [12]. Re-
search advancements in neural mechanisms of fear ex-
tinction are promising to provide a way for improving
these therapeutic methods. As the GABAergic system
is known to be a key player in fear extinction, these
novel observations regarding the modulatory effect of
eGABAARs in the MD on fear extinction may propose
a potential target for developing new therapeutic
methods, or provide a potential mechanism for exist-
ing treatments for conditions like PTSD.
Methods
Mice
Adult (12–16 weeks old) male wild-type F1 (B6 × 129)
hybrid mice, used for the drug infusion experiments,
were obtained by mating parental strains of C57BL/6J
and 129s4/svJ. For the virus injection experiments, adult
male (12–16 weeks old) B6.GABRA4flx/flx mice were
used. B6.GABRA4flx/flx mice were produced by mating
B6.GABRA4flx/+mice. Mice had ad libitum access to
food and water and were housed under a 12:12 hr light/
dark cycle (lights on at 8 AM). Animal care and experi-
ments followed the guidelines from the Institutional
Animal Care and Use Committee of Institute for Basic
Science.
Fear conditioning and extinction
The mice went through fear conditioning, extinction,
and extinction recall as described previously [5]. Briefly,
the mice were conditioned in conditioning chamber
(context A) using three trials of CS + US: tones (3 KHz,
30 s, and 85 dB) co-terminating with foot shocks
(0.35 mA, 1 s). For the B6GABRA4flx/flx mice, five trials
of tone and foot shock (0.7 mA) were used. The inter-
trial interval was 120 s. After 24 hr, mice were exposed
to twenty CS-only (tone) trials in the extinction box
(context B) with an intertrial interval of 5 s. For the
extinction recall test, mice were exposed to the tone on
the third day (context B).
Mice behavior was recorded with a video camera to
score freezing (lack of movement except for respiration)
using the FreezeFrame software (Actimetrics, Coulbourn
Instruments, PA, USA).
Open field test
Locomotor activity was tested in an open field box
(40×40×50 cm) as reported previously, one week apart
from fear conditioning and extinction [5]. The ratio of
the time spent in the central 20×20 cm area to the time
spent in the whole 40×40 cm arena in the first 5 min
was used as a measure of anxiety. Automated measure-
ments were done using EthoVision software (Noldus
Information Technology, Netherlands).
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Mice were anesthetized using intraperitoneal injection of
2% Avertin solution (tribromoethyl alcohol/tertiary amyl
alcohol, vol/vol, Sigma-Aldrich), and framed in stereo-
taxic device (Kopf instruments, CA, USA). Mouse sur-
gery for unilateral implantation of guide cannula was
done according to the protocols [5], targeting the MD
(AP: −1.5 mm, ML: 0.3 mm, and DV: −3.3 mm from the
brain surface). Gabazine or THIP (from Sigma-Aldrich, St.
Louis, MO, USA) were dissolved in normal saline, and a
volume of 0.3 μl (30 and 50 μM, respectively) was infused
(0.1 μlmin−1) through a 33-gauge injection cannula inserted
in the guide cannula. The injector was kept in place for
3 min after the end of the injection. Histologic con-
firmation of the infusion position was carried out and
only the data from properly injected mice were used
for statistical analysis.
Production and injection of recombinant AAV-mCherry-
Cre and AAV-mCherry
For AAV2 production, we used the pAAV-MCS plasmid
(Stratagene, La Jolla, CA) carrying the cDNA for mCherry-
Cre (NLS-Cre was kindly provided by Dr. C. Justin Lee,
KIST) or mCherry downstream of the CMV promoter. For
recombinant virus generation, AAV-293 cells were co-
transfected with pAAV-RC (Stratagene) encoding the AAV
genes rep and cap and the helper plasmid (Stratagene) en-
coding E24, E4 and VA. Virus particles were purified and
concentrated according to the procedure [38]. The AAV
viral titer was determined using a QuickTiterTM AAV
Quantitation Kit (Cell Biolabs, San Diego, CA) and a mini-
mum titer of 1011/ml was obtained. The AAV-mCherry
control or AAV-mCherry-Cre virus was injected in the MD
region (AP: −1.5 mm, ML: 0.3 mm, and DV: −3.3 mm from
the brain surface) of B6GABRA4flx/flx mice unilaterally,
using a Hamilton syringe connected to a microinjection
pump (sp100i instrument, WPI, USA) with a volume of
0.6 μl at a rate of 0.1 μlmin−1. The needle was held in place
for 10 min after completion of the injection to permit the
diffusion of the viral particles into the brain tissue.
Immunohistochemistry and immunofluorescence
To check Cre and α4-subunit expression in the MD, we
performed histology as described previously [39]. Mice
were perfused transcardially with cold saline, followed
by 4% paraformaldehyde in phosphate-buffered saline
(PBS) (10 mM, pH 7.4) under Avertin anesthesia. Brains
were postfixed in 4% paraformaldehyde overnight at 4°C.
Coronal sections (50 μm thickness) of the MD were pre-
pared using a vibratome (VT1200S, Leica, Germany).
For diaminobenzidine (DAB) immunostaining, free-
floating sections were initially washed (3×) in PBS, and
then cell membranes were permeabilized using PBS sup-
plemented with 0.1% Triton X-100 (PBST) for 10 minand then incubated in 0.3% H2O2 in PBS (20 min). Next,
tissue was blocked (1 h) in 5% goat serum⁄PBS and incu-
bated (overnight, 4°C) in a rabbit polyclonal anti α4-subunit
antibody (1:1000 final dilution, ab4120 abcam, UK). After
3× washes in PBS, sections were incubated (2 h) at room
temperature (25°C) in biotinylated anti-rabbit IgG (1:500,
Vector Laboratories, Burlingame, CA, USA) and then
placed in an avidin⁄biotin horseradish peroxidase complex
for 1 h (prepared according to the manufacturer’s instruc-
tions, Vector Laboratories). The signal was visualized by
the addition of diaminobenzidine-nickel-intensified sub-
strate (Vector Laboratories, USA), mounted on gelatin-
coated slides and coverslipped with Permount media
(Fisher Scientific, Houston, TX, USA).
For fluorescent immunolabeling against Cre, tissue sec-
tions were incubated (overnight, 4°C) with mouse monoclo-
nal anti-Cre antibody (1:1000, MAB3120, EMD Millipore,
Germany). The sections were washed with PBS and then
incubated (2 h at room temperature) with an Alexa 488-
conjugated anti-mouse IgG antibody (1:500, Molecular
Probes, Eugene, OR, USA). Sections were washed in PBS,
and then incubated (30 min) with the DNA stain 4′,6-dia-
midino-2-phenylindole (DAPI) (Thermo Scientific, USA),
washed in PBS again, and then mounted with VECTA-
SHIELD (Vector Laboratories, Inc. Burlinggame, CA,
USA).
Images of diaminobenzidine-labeled sections were
captured using a light microscope (ECLIPSE Ti, Nikon,
Japan). For fluorescent imaging, a confocal microscope
(IX81, Olympus, Japan) was used.
Figures were prepared using Adobe Photoshop CS6
(Adobe Systems Inc., USA) and Microsoft Office 2010
(Microsoft Corporation, Redmond, USA). Image manipula-
tion was restricted to threshold and brightness adjustments
applied to the entire image.
Data analysis
Making graphs, two-way repeated measures ANOVA, t test
or equivalent non-parametric tests were done using the
Sigmaplot software (Systat Software Inc., USA).
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